Chemerin, OPG , and WPOI as Markers of Bone Invasion and Prognosis in Oral Squamous Cell Carcinoma
Journal of Oral Pathology & Medicine · 2026
DOI: 10.1111/jop.70068 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Oral Pathology & Medicine, 2026. Verfasst von Jonas Eichberger und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oral and Maxillofacial Surgery, University Hospital Regensburg, Regensburg, Germany. Hauptthemen laut MEDLINE: Mouth Neoplasms, Carcinoma, Squamous Cell, Osteoprotegerin, Chemokines. Die Arbeit nennt 34 Literaturangaben.
Abstract (Originalsprache)
Background
The objective of our study was to examine the role of Chemerin, Chemokine like receptor 1 (CMKLR1), receptor activator of nuclear factor kappa‐Β ligand (RANKL), and Osteoprotegerin (OPG) in the development of bone‐invasive oral squamous cell carcinoma.
Methods
In order to evaluate the presence of these markers at the interface between bone and tumor, immunohistochemical analyses were conducted using tissue microarrays obtained from 164 patients with oral squamous cell carcinoma growing in close contact with jaw bone.
Results
The findings indicate that Chemerin and Osteoprotegerin are notably reduced in tumors that have invaded the bone. Only 21 (32.8%) of pT4a tumors (defined as bone invasive) had a high Osteoprotegerin expression, whereas 36 (66.7%) of pT2 and pT3 tumors demonstrated high expression of Osteoprotegerin ( p < 0.001). Similarly, we saw a downregulation of Chemerin in 50 (60.2%) bone invasive oral squamous cell carcinoma samples compared to 28 (35.0%) in non‐bone invasive tumors ( p = 0.002). In addition, our data indicated a connection between worst pattern of invasion score and less favorable overall and disease‐specific survival ( p = 0.007 and p = 0.024, respectively).
Conclusions
The findings suggest that Chemerin and Osteoprotegerin have the potential to serve as indicators for bone invasion in oral squamous cell carcinoma, which could have significant implications for diagnosis and treatment approaches.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Oral and Maxillofacial Surgery, University Hospital Regensburg, Regensburg, Germany.
- Tumor Center Regensburg, Institute for Quality Assurance and Health Services Research, University of Regensburg, Regensburg, Germany.
- Department of Internal Medicine I, University Medical Center Regensburg, Regensburg, Germany.
- Department of Oral and Maxillofacial Surgery and Center for Medical Biotechnology, University Hospital Regensburg, Regensburg, Germany.
- Institute of Pathology, University of Regensburg, Regensburg, Germany.
ORCID-Profile: Jonas Eichberger
Zitieren
APA
Eichberger, J., Schmelzer, J., Gerken, M., Buechler, C., Schulz, D., Fiedler, M., Eckmueller, S., Gottsauner, J. M., Bauer, R., Reichert, T. E., Weber, F., & Ettl, T. (2026). Chemerin, OPG , and WPOI as Markers of Bone Invasion and Prognosis in Oral Squamous Cell Carcinoma. Journal of Oral Pathology & Medicine. https://doi.org/10.1111/jop.70068
Vancouver
Eichberger J, Schmelzer J, Gerken M, Buechler C, Schulz D, Fiedler M, et al. Chemerin, OPG , and WPOI as Markers of Bone Invasion and Prognosis in Oral Squamous Cell Carcinoma. Journal of Oral Pathology & Medicine. 2026. doi:10.1111/jop.70068
BibTeX
@article{Eichberger2026,
author = {Eichberger, Jonas and Schmelzer, Juliane and Gerken, Michael and Buechler, Christa and Schulz, Daniela and Fiedler, Mathias and Eckmueller, Stephanie and Gottsauner, Josef Maximilian and Bauer, Richard and Reichert, Torsten Eugen and Weber, Florian and Ettl, Tobias},
title = {Chemerin, OPG , and WPOI as Markers of Bone Invasion and Prognosis in Oral Squamous Cell Carcinoma},
journal = {Journal of Oral Pathology & Medicine},
year = {2026},
doi = {10.1111/jop.70068}
}
EUVIMED